AI assistant
Sending…
Adicet Bio, Inc. — Director's Dealing 2019
May 15, 2019
34412_dirs_2019-05-15_c5f5065f-02cc-4198-bf48-6b39d0aef16d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-05-13
Reporting Person: Klickstein Lloyd (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-13 | Stock Option (Right to Buy) | $8.08 | A | 295000 | Acquired | 2029-05-12 | Common Stock (295000) | Direct |
Footnotes
F1: 25% of the shares shall vest on May 13, 2020, and the remaining shares shall vest in 12 equal quarterly installments thereafter.
More from Adicet Bio, Inc.
Annual Report
2026
May 20
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Mar 24
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27